Beneficial ownership — 13D / 13G
85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Blackstone Holdings II L.P. | ALIT Alight, Inc. / Delaware | 13D/A | 6.24% | Dec 19, 2023 | 2y |
| Saba Capital Management, L.P. | DMA Destra Multi-Alternative Fund | 13D/A | 12.56% | Dec 19, 2023 | 2y |
| BAKER BROS. ADVISORS LP | NGNE Neurogene Inc. | 13D/A | 4.99% | Dec 18, 2023 | 2y |
| Pittman Scott M. | AURX Nuo Therapeutics, Inc. | 13D/A | 12.1% | Dec 18, 2023 | 2y |
| Firment Shipping Inc. | GLBS Globus Maritime Ltd | 13D/A | 23.5% | Dec 18, 2023 | 2y |
| Jeffrey A. Ferrell | BIOR Biora Therapeutics, Inc. Common Stock | 13D/A | 49.9% | Dec 18, 2023 | 2y |
| CYVN Investments RSC Ltd | NIO NIO Inc. | 13D/A | 7.6% | Dec 18, 2023 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | PNT POINT Biopharma Global Inc. Common Stock | 13D/A | 0% | Dec 18, 2023 | 2y |
| REH Company | DINO HF Sinclair Corp | 13D/A | 14% | Dec 18, 2023 | 2y |
| Charles S. Leykum | RNGR Ranger Energy Services, Inc. | 13D/A | 16.6% | Dec 18, 2023 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | GPCR Structure Therapeutics Inc. | 13G/A | 1.8% | Dec 18, 2023 | 2y |
| Wojciech Hlibowicki | RUM RUM Group Inc. | 13D/A | 5.5% | Dec 17, 2023 | 2y |
| Michael A. Davis (“Davis”) | CYAN Cyanotech Corp | 13D/A | 19.7% | Dec 15, 2023 | 2y |
| Barry J. Renbaum | FMFG Farmers & Merchants Bancshares, Inc. | 13D/A | 9.9% | Dec 15, 2023 | 2y |
| Brandon Alexandroff | RUM RUM Group Inc. | 13D/A | 6.7% | Dec 15, 2023 | 2y |
| IAF, LLC | ERNA Ernexa Therapeutics Inc. | 13G | 9.99% | Dec 14, 2023 | 2y |
| G&C International Investment Co., Ltd. No I.R.S Identification Number | DAZSF ZKGC New Energy Ltd | 13D/A | 56.35% | Dec 14, 2023 | 2y |
| LSV Associates, LLC | ALXO Alx Oncology Holdings Inc | 13D/A | 8.4% | Dec 13, 2023 | 2y |
| Irenic Capital Management LP | RSVR Reservoir Media, Inc. | 13D | 5.1% | Dec 12, 2023 | 2y |
| Cleveland Avenue Food and Beverage Fund II, LP | PRST Presto Technologies, Inc. Common Stock | 13D/A | 17.1% | Nov 21, 2023 | 2y |
| Ionic Ventures, LLC | BBLG Bone Biologics Corp | 13G/A | 9.99% | Nov 16, 2023 | 2y |
| 210 Capital, LLC | RPC Ridgepost Capital, Inc. | 13D | 20.9% | Oct 23, 2023 | 2y |
| Nistec Golan Ltd. | ELTK Eltek Ltd | 13D/A | 62.72% | Oct 4, 2023 | 2y |
| Coliseum Capital Management, LLC | UTI Universal Technical Institute Inc | 13D/A | 24.9% | Dec 18, 2023 | 2y |
| Exor N.V. | CLVT Clarivate PLC | 13D/A | 9.62% | Dec 18, 2023 | 2y |
| Warren B. Kanders | CLAR Clarus Corp | 13D/A | 15.4% | Dec 18, 2023 | 2y |
| Craig J. Duchossois | CHDN Churchill Downs Inc | 13D/A | 4.4% | Dec 18, 2023 | 2y |
| Mudrick Capital Management, L.P. | GETR Getaround, Inc. | 13D/A | 23.3% | Dec 15, 2023 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | ACIU AC Immune SA | 13G/A | 14.8% | Dec 15, 2023 | 2y |
| Abdiel Qualified Master Fund, LP | CRCT Cricut, Inc. | 13G | 17.9% | Dec 15, 2023 | 2y |
| Alibaba Group Holding Ltd | XPEV Xpeng Inc. | 13D/A | 9.2% | Dec 15, 2023 | 2y |
| Green Equity Investors CF, L.P. | ASLE AerSale Corp | 13D/A | 18.6% | Dec 15, 2023 | 2y |
| Mill Road Capital III, L.P. | CULP Culp Inc | 13D/A | 4.7% | Dec 15, 2023 | 2y |
| Daniel R. Revers | OPAL OPAL Fuels Inc. | 13D/A | 1.4% | Dec 15, 2023 | 2y |
| Rolf Schrömgens | TRVG trivago N.V. | 13D/A | 18.2% | Dec 14, 2023 | 2y |
| Nierenberg Investment Management Company, LLC | FTK Flotek Industries Inc | 13D/A | 4.4% | Dec 14, 2023 | 2y |
| MCI Capital, LC | SRT Startek Inc. | 13D/A | 7.56% | Dec 14, 2023 | 2y |
| Phoenix Financial Ltd. | KMDA Kamada Ltd | 13G/A | 4.16% | Dec 14, 2023 | 2y |
| Sangwoo Park | NKGN NKGen Biotech, Inc. Common Stock | 13D/A | 53.18% | Dec 13, 2023 | 2y |
| Braden Ferrari | BTLN Brightline Interactive, Inc. | 13G/A | 5.19% | Dec 13, 2023 | 2y |
| Millennium Management LLC | CDMO Avid Bioservices, Inc. Common Stock | 13G | 7.3% | Dec 12, 2023 | 2y |
| PL Capital Advisors, LLC | BANC Banc Of California, Inc. | 13D/A | 1.9% | Dec 1, 2023 | 2y |
| Findell Capital Partners LP | EHTH eHealth, Inc. | 13G | 5.1% | Nov 8, 2023 | 2y |
| NewGen Asset Management Ltd | ELBM Electra Battery Materials Corp | 13G | 9.9% | Aug 31, 2023 | 2y |
| Peter J. Nolan | LMNR Limoneira CO | 13D/A | 6.1% | Dec 15, 2023 | 2y |
| HGGC Fund IV GP, Ltd. | UPLD Upland Software, Inc. | 13D/A | 18.85% | Dec 15, 2023 | 2y |
| Richard Gebbia | SIEB Siebert Financial Corp | 13D/A | 43% | Dec 14, 2023 | 2y |
| Meridian Venture Partners II GP, L.P. ("GP") | ANIP Ani Pharmaceuticals Inc | 13D/A | 8.2% | Dec 14, 2023 | 2y |
| Ming Ni | MATH Metalpha Technology Holding Ltd | 13D/A | 7.9% | Dec 14, 2023 | 2y |
| Fosun International Ltd | LANV Lanvin Group Holdings Ltd | 13D/A | 58.65% | Dec 14, 2023 | 2y |